The executive president of the Nicaraguan Institute of Social Security (INSS), Roberto López, reported this Thursday that Interferon Alpha 2B, a Cuban drug that is used within the spectrum of drugs to treat patients infected by coronavirus, could begin to be produced in Nicaragua .
López, made a tour of the Mechnikov vaccine plant (Managua) together with the deputy director of the Center for Genetic Engineering and Biotechnology (CIGB) of Cuba, Marta Ayala. Both specialists valued the possibility of starting the preparation process for the production of the Cuban medicine.
Ayala, expressed that the visit is an expression of solidarity and brotherhood among the peoples of Latin America to share knowledge and fight together the coronavirus pandemic. “We think that from the governments, the authorities, we must be prepared for this epidemic, for which each one of the citizens must be very active, investigating ourselves, alerting but also preparing ourselves, therapeutically speaking, to be able to care for the sick that may arise” , he assured.
The intention of both governments is to have a retroviral production capacity in the Central American country to attend to its patients and at the same time function as the closest point of sale to the rest of the countries in the region under the operations of the Grupo de las Industrias Biotechnology and Pharmaceutical of Cuba (BioCubaFarma).